NCT06215079

Brief Summary

The aim of our study is to investigate transcranial magnetic stimulation (TMS) as a treatment option in Complex Regional Pain Syndrome, disseminate it to a broader patient population, and simultaneously demonstrate its applicability in the treatment of complex regional pain syndrome using a novel frequency matching.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

January 9, 2024

Last Update Submit

January 18, 2024

Conditions

Keywords

complex regional pain syndrometranscranial magnetic stimulationischemic stroke

Outcome Measures

Primary Outcomes (3)

  • Visual Analog Scale (VAS)

    A 10 cm Visual Analog Scale (VAS) has been used to objectively assess widespread body pain in patients. Participants use this scale to determine the intensity of their pain. While 0 represents no pain, 10 indicates the most severe pain experienced by the individual.

    Before the treatment, At the end of the treatment (1 week), Four weeks after the treatment

  • Brunnstrom's Hemiplegia Recovery Staging

    According to Brunnstrom, the stages of recovery in patients developing paralysis due to stroke progress as follows: Stage 1, where muscles are completely flaccid; Stage 2, the emergence of muscle synergies; Stage 3, the peak of involuntary movements; Stage 4, a decrease in involuntary movements and the initiation of voluntary movements; Stage 5, the appearance of more coordinated movements; Stage 6, the disappearance of spasms and the observation of fine joint movements, approaching near-complete recovery; Stage 7, where all functions return to normal.

    Before the treatment, At the end of the treatment (1 week), Four weeks after the treatment

  • Stroke Specific Quality of Life Scale (SS-QoL)

    The SS-QoL is an instrument specifically used to assess health-related QoL among individuals who experienced stroke. It has 49 items in 12 domains, varying from 49 to 245 points, with responses varying from 1 to 5 points. Higher values indicate better health-related QoL.

    Before the treatment, At the end of the treatment (1 week), Four weeks after the treatment

Secondary Outcomes (1)

  • Fugl Meyer Upper Extremity Assessment

    Before treatment (initial), at the end, four weeks after treatment

Study Arms (3)

active transcranial magnetic stimulation in stroke patients with complex regional pain syndrome

ACTIVE COMPARATOR

The intermittent theta-burst stimulation (iTBS) intensity for patients, applied under doctor supervision for a total of 5 days over one week (from Monday to Friday), will be set at 70% of the resting motor threshold. Stimulation will consist of bursts at a frequency of 50 Hz, with 3 bursts every 10 seconds, each burst lasting 2 seconds, totaling 600 bursts. Subsequently, the resting motor threshold will be adjusted to 80%, and a total of 2000 bursts will be delivered at a frequency of 10 Hz, repeated every 30 seconds, each lasting 10 seconds.

Device: The Magstim Rapid2 Plus Magnetic Stimulator (Magstim, Whitland, Dyfed, UK)

sham transcranial magnetic stimulation in stroke patients with complex regional pain syndrome

SHAM COMPARATOR

Similar protocol will be applied and sham transcranial magnetic stimulation treatment will be given with a sham coil to the sham group.

Device: Sham transcranial magnetic stimulation

conventional rehabilitation program in stroke patients with complex regional pain syndrome

PLACEBO COMPARATOR

Only a conventional rehabilitation program consisting of discontinuous ultrasound, transcutaneous electrical nerve stimulation (TENS), and contrast bath, formed by 5 sessions, will be applied to this group.

Device: conventional rehabilitation program

Interventions

Transcranial Magnetic Stimulation (rTMS) is a non-invasive brain stimulation method that modulates the cortical excitability of the targeted motor area. While single-pulse TMS is generally used to explore the functioning of the brain, repetitive TMS is employed to induce lasting changes in brain activity. High-frequency rTMS leads to an increase in excitability in the motor cortex, whereas low-frequency application results in inhibition of motor cortical excitability. Theta-burst stimulation (TBS) is a form of rTMS that can be delivered continuously (cTBS) or intermittently (iTBS), thus modulating the excitability of corticospinal neurons beneath the stimulation area to either decrease or increase. rTMS is a growing research area in pain management, proven to be a safe and well-tolerated method. Studies have shown that rTMS applied to the motor cortex is a promising treatment method for chronic pain

active transcranial magnetic stimulation in stroke patients with complex regional pain syndrome

Patients in the control group will receive sham transcranial magnetic stimulation with sham coil for 35 minutes a day, 5 sessions in total, together with conventional rehabilitation.

sham transcranial magnetic stimulation in stroke patients with complex regional pain syndrome

Patients will receive 5 minutes of continuous ultrasound (1MHz, 2W/cm2, 1:4)), followed by a 20-minute contrast bath, and 15 minutes of TENS (frequency: 100 Hz; pulse duration: 50-100 ms; and amplitude adjusted to avoid discomfort or muscle contraction to the patient).

conventional rehabilitation program in stroke patients with complex regional pain syndrome

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Complex Regional Pain Syndrome Diagnosis of ischemic stroke

You may not qualify if:

  • Epilepsy Pregnancy Cardiac Pacemaker, Brain pacemaker, Cochlear Implants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital Physical Therapy and Rehabilitation Hospital

Ankara, 06800, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Gaertner M, Kong JT, Scherrer KH, Foote A, Mackey S, Johnson KA. Advancing Transcranial Magnetic Stimulation Methods for Complex Regional Pain Syndrome: An Open-Label Study of Paired Theta Burst and High-Frequency Stimulation. Neuromodulation. 2018 Jun;21(4):409-416. doi: 10.1111/ner.12760. Epub 2018 Mar 4.

    PMID: 29504190BACKGROUND
  • Chang MC, Kwak SG, Park D. The effect of rTMS in the management of pain associated with CRPS. Transl Neurosci. 2020 Sep 28;11(1):363-370. doi: 10.1515/tnsci-2020-0120. eCollection 2020.

    PMID: 33335776BACKGROUND
  • Nardone R, Brigo F, Holler Y, Sebastianelli L, Versace V, Saltuari L, Lochner P, Trinka E. Transcranial magnetic stimulation studies in complex regional pain syndrome type I: A review. Acta Neurol Scand. 2018 Feb;137(2):158-164. doi: 10.1111/ane.12852. Epub 2017 Oct 3.

    PMID: 28971481BACKGROUND

Related Links

MeSH Terms

Conditions

Complex Regional Pain SyndromesIschemic Stroke

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Hüma Bölük Şenlikçi Associate Professor

CONTACT

Özlem Yücealp Ali Medical Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant in Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 9, 2024

First Posted

January 22, 2024

Study Start

November 15, 2023

Primary Completion

April 15, 2024

Study Completion

December 15, 2024

Last Updated

January 22, 2024

Record last verified: 2024-01

Locations